ID: ALA3220798

Max Phase: Preclinical

Molecular Formula: C32H65N5O10S

Molecular Weight: 711.96

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCCCCCCCCCCCCS(=O)(=O)C[C@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)[C@@H](O)C[C@H]3N)[C@@H](N)C[C@H]2N)[C@H](O)[C@@H](N)[C@@H]1O

Standard InChI:  InChI=1S/C32H65N5O10S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-48(42,43)18-24-26(39)25(37)27(40)32(45-24)47-30-20(35)15-19(34)29(28(30)41)46-31-21(36)16-22(38)23(17-33)44-31/h19-32,38-41H,2-18,33-37H2,1H3/t19-,20+,21+,22-,23+,24+,25-,26+,27+,28-,29+,30-,31+,32+/m0/s1

Standard InChI Key:  OXZADSXQILJNEJ-GWEZSMEQSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 711.96

Molecular Weight (Monoisotopic): 711.4452

AlogP: -1.17

#Rotatable Bonds: 20

Polar Surface Area: 282.08

Molecular Species: BASE

HBA: 15

HBD: 9

#RO5 Violations: 3

HBA (Lipinski): 15

HBD (Lipinski): 14

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 12.53

CX Basic pKa: 9.57

CX LogP: -1.19

CX LogD: -7.50

Aromatic Rings: 0

Heavy Atoms: 48

QED Weighted: 0.07

Np Likeness Score: 0.75

References

1. Herzog IM, Feldman M, Eldar-Boock A, Satchi-Fainaro R, Fridman M.  (2013)  Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity,  4  (1): [10.1039/C2MD20162C]

Source

Source(1):

• Scientific Literature